Dosages (Ginger) — 3–10 g fresh ginger, or 2–4 g dry ginger, 1–3 ×/day (JAD; SKY); 0.3–1.5 g rhizome several ×/day (MAD); 500–1000 mg fresh root 3 ×/day (MAB); 2–4 tbsp fresh root (PED); 3–6 g dry root (PED); 4.5 g dry root:22 ml alcohol/23 ml water (PED); 500 mg dry root 2–4 ×/day –(MAB); 0.3–1 g powdered root (PNC); 2 tsp powdered root/cup water (APA); 0.25–1.0 g herb, or in tea, 3 ×/day (CAN); 0.7–2 ml liquid extract (1:2)/day (MAB); 0.25–3 ml herbal tincture (CAN; SKY); 0.25–3 ml tincture (PNC); 1.7–5 ml tincture (1:5)/day (MAB); 1.5–9 g/day (FAY); 2–4 g/day (HH3); 500 mg tablet 2–4 ×/day (MAB); 3 (530 mg) capsules 3 ×/day (NH); 1 (480 mg) StX 2 ×/day; 15–60 mg ginger oleoresin (PNC); 2.5–5 ml ginger syrup (PNC). Contraindications, Interactions, and Side Effects (Ginger) — Class 2b, 2d (AHP).“Hazards and/or side effects not known for proper therapeutic dosages” (PH2). Perhaps erring on the side of caution, Reichert cautions that ginger may raise the blood pressure, may amplify blood-thinning drug activities, and might be contraindicated in pregnancy. Contraindicated in childhood fevers and gallstones (WAM). Patients with gallstones should consult a practitioner before taking ginger (AHP). The Lawrence Review says overdoses may cause cardiac arrhythmias and CNS depression (LRNP, November 1991). Large doses (6 g or more) possibly gastroirritant, causing a significant increase in exfoliation of gastric surface epithelial cells in human volunteers (MAB). Due to ginger’s strong antiaggregant activity, experts recommend it not be used by people with blood clotting disorders. Many chemotherapy patients experience periods when their blood platelet counts drop dramatically. Doctors will warn patients to avoid aspirin when their platelet counts are low. They feel that patients should also avoid ginger when their platelet count drops, while continuing use of ginger for patients with normal platelet counts. Less conservatively, Commission E reports rhizome should not be used for vomiting in pregnancy (AEH). Lininger et al. (1998) adds heartburn as a rare side effect. “A doctor should be informed if ginger is used before surgery to counteract possible postanesthesia nausea” (SKY). Extracts (Ginger) — Fresh ginger juice reduces serum glucose levels in experimental animals (PED). Both fresh and dry rhizome suppress gastric contractions and reduce vomiting (PNC). Gingerols and shogaols are analgesic, antipyretic, antiprostaglandin, antiulcer, hepatoprotective, and hypotensive (PNC). As carminatives, the EOs, oleoresins, and proteolytic enzymes stimulate digestion, helping combat the effects of overeating, improper chewing, or excessive motion. They increase gastric motility and neutralize acids and toxins in the digestive tract (PED). Gingerol and 6-gingerol inhibit gastric ulceration in rats. I suspect there’s synergy at work in the antiulcer phytochemicals in ginger. 6-Gingesulfonic acid is less pungent but more potent against ulcers than 6-gingerol or 6-shogaol (MAB). Oral spray dried ginger (500 mg/kg) or combinations ginger and licorice extracts (1000 mg/kg), significantly prevented gastric mucosal damage induced by ethanol in rats. Pretreatment with these inhibited the reduction in the deep corpus mucin content caused by ethanol (MAB). As a powerful thromboxane-synthetase inhibitor and prostacyclin agonist, ginger has potential as an antidepressant, in alcohol withdrawal and the complications of liver damage, and in treating a side effect of alcoholism, impotence, in preventing aging penile vascular changes. LD50 ginger oil = >5000 mg/kg orl rat (MAB), LDlo ginger extract = >2300 mg/kg orl mouse, equivalent to 75,000 mg/kg ginger (MAB). Ginger extract equal to aspirin in antiedemic activity; 940 mg powdered ginger is more effective than 100 mg dimenhydrinate for kinetosis (motion sickness); ginger is equal to metoclopramide for postoperative nausea and vomiting (WHO). 8 Gingerol more potently inhibited the response to serotonin than the control drug, cocaine (MAB). Gingerols are more potent at inhibiting prostaglandin synthesis than indomethacin (MAB). Ginger extract inhibited swelling as actively as aspirin (MAB). Shogaol as antitussive as dihydrocodeine (TRA).
Recipes with Ginger—take a length o Ginger about 3-6 inches and peel—add to blender—add honey ¼-1/2 cup ( unpasteurized) if you cannot get that use what is at your disposal –Raw—Unheated ( if it is not unpasteurized chances are it has been microwaved—called flash pasteurizing )—add ½ ounce of any type of drinking alcohol—allow to blend til it is totally fused ( should take about 5-7 minutes )pour into a GLASS container—use it for alertness—pylori—circulation—digestion—healing—pain and assorted uses
Recipe Combo with Ginger—take the 3-6 inch of ginger—peel it and add to blender—pour a ½ cup of wine –add either powdered cayenne 1 heaping tablespoon ( or more if you really like this hot) blend this at high speed for 10 minutes —strain bottle it in glass and use it in ½ – 1 tsp increments ( if giving this to kids dilute it in either honey or oil this is potent) Great for pain—Heart—Circulation—Bacterial—Fungal—Viral—Stomach—Liver Support and a host of other things
High Fructose Corn Syrup Linked to Liver Scarring
Study ties the ubiquitous sweetener to non-alcoholic fatty liver disease—URL of this page: http://www.nlm.nih.gov/medlineplus/news/fullstory_96629.html FRIDAY, March 19 (HealthDay News) — New research links consumption of high-fructose corn syrup, the extremely popular sweetener that shows up in food products from ketchup to jelly, to liver damage in people with non-alcoholic fatty liver disease. It’s not clear if the sweetener directly causes liver scarring, also known as fibrosis, but those who consumed more of the sweetener appeared to have more liver scarring, according to the report released online in advance of publication in an upcoming print issue of the journal Hepatology. “We have identified an environmental risk factor that may contribute to the metabolic syndrome of insulin resistance and the complications of the metabolic syndrome, including liver injury,” Dr. Manal Abdelmalek, associate professor of medicine in the division of gastroenterology/hepatology at Duke University Medical Center and leader of a team of scientists behind the new research, said in a university news release. The researchers examined the medical records of 427 adults with non-alcoholic fatty liver disease (NAFLD), along with questionnaires the patients completed about their diets. –Only 19 percent of adults with non-alcoholic fatty liver disease said they never drank beverages containing the sweetener; 29 percent did so every day, the investigators found. —“Non-alcoholic fatty liver disease is present in 30 percent of adults in the United States,” Abdelmalek said in the news release. “Although only a minority of patients progress to cirrhosis, such patients are at increased risk for liver failure, liver cancer, and the need for liver transplant. Unfortunately, there is no therapy for non-alcoholic fatty liver disease. My hope is to see if we can find a factor, such as increased consumption of high-fructose corn syrup, which if modified, can decrease the risk of liver disease.”–Representatives of the corn refining industry took issue with the findings, noting that the study involved a wide range of sources of fructose, not just beverages sweetened with high-fructose corn sugar. Furthermore, “fructose has not been proven to be a cause of NAFLD in humans, and NAFLD subjects are compromised individuals with significant health problems which have very little to do with fructose intake,” according to a news release from the Corn Refiners Association released late Friday.—“Moreover, associative studies of this kind are widely judged to be of low scientific value when trying to establish cause-and-effect, data from studies like this that are dependent on recollection of the study subjects are notoriously imprecise, and these studies are full of confounding variables and exceedingly difficult to control,” the CRA added.—SOURCE: Duke University Medical Center, news release, March 18, 2010; March 19, 2010, news release, Corn Refiners Association
EFSA sets new DRV for carbs, fats and water
The European Food Safety Authority published new dietary reference values (DRVs) for carbohydrates, sugar, fibre, fats and water confirming proposals made last year. The final levels have drawn criticism from some scientists. The EU risk assessor was asked by the European Commission to update DRVs for a slate of nutrients on the basis of the most recent scientific evidence, as the last time these were set was in 1993. The values released today are the first of three batches: advice on protein and energy is in the works, and EFSA will start working on vitamins and minerals later this year. EFSA held public consultations on the new DRVs prior to confirming them. The values will now be used as an evidence base underpinning nutritional policies, public health targets, and consumer info and education programmes.
Carbs, sugar and fibre
EFSA’s advice on total carbohydrates is that intake should comprise between 45 and 60 per cent of total energy intake for both adults and children. A daily intake of 25g of fibre is recommended for normal bowel function in adults; II( Totally absurd—anyone eating this much carb as either a fibre or food will wind up depleting there minerals as well as taxing certain organs as well—not to mention the brain deficiency this will cause over a period of time—and the allowance of diseases that will thrive in this type of environment—such as parasites—yeast—and fungal—amoebic as well ) EFSA has also recognised evidence linking fibre to reduced risk of cardiovascular disease and type 2 diabetes, and its role in weight management. II ( yes it will manage to increase body mass as a result of insulin imbalancing—totally absurd )
However it could not find sufficient evidence to support the role of the glycaemic index and glycaemic load in maintaining weight and preventing diet-related diseases. —No upper limit for sugars has been set, either, because of insufficient evidence and health effects are a matter ofII what foods are consumed and how often, rather than the amount of sugar per se.( again setting standards to conform to a global directive an impossible standard due to the environmental and life styles of different people from different parts of the planet ) II The panel does recognise that there is “good evidence that frequent consumption of foods high in sugars increases the risk of tooth decay”( if this breaks down bone what about your organs and glands?? Scientist or quackery—either way it is a religion I do not want to join —this stupidity will break you down and cause all kinds of deficiencies as well injuries due to the sugar and yeast and fungal environment that this amount of starchy sugar will create. But says policy makers should consider evidence for consumption patterns of sugar-containing foods when making national nutrition recommendations.
Overall, EFSA says fat intakes should range between 20 and 35 per cent of total energy for adults (the values for children are adjusted to take account of their developmental needs). But evidence for impact of different kinds of fat is recognised, such as the link between saturated and trans fats and blood cholesterol levels. Here too, though, EFSA leaves it to national policy makers to decide how to couch the message that mono- and poly-unsaturated fatty acids are better than trans and saturated. In the case of long-chain omega-3 fatty acids, however, it is more prescriptive. It says a daily intake of 250mg for adults “may reduce the risk of heart disease”. II( another line of BS—the PCB’s and the mercury will cause thyroid and brain issues ) However academics and industry have been lobbying for far higher values than this – ideally over 500mg a day. Following the publication of the proposed values, a 22-strong of scientists wrote to EFSA to ask it to “reconsider its conclusions and advice on omega-3 fatty acids afresh, right from the beginning.” II ( again this will be about who they are representing and the money trail )The scientists also objected to the proposal that ALA (alpha-linolenic) acid is a “viable precursor” to longer-chain DHA and EPA fatty acids. EFSA’s final opinion states that “ALA cannot be synthesised by the body, is required to maintain metabolic integrity, and is therefore considered to be an essential fatty acid”. It proposes an adequate intake level of 0.5 per cent of energy, but says there is not enough evidence to set an average requirement, a lower threshold intake or a population reference intake. It also sees no need for a tolerable upper intake level, as it says there is no convincing evidence of any detrimental health effects. The final DRV included in the current batch is for water. EFSA says 2 litres a day is considered adequate for women, and 2.5 litres for men.